PharmaRoth Labs, Inc. (ROTH)

[old biohf guy]

sweetlou, thanks for posting this. I agree with your assessment. If the clinical trial results are anywhere close to what is expected, Sucanon should get some serious attention in the medical/drug community.

A quick comparison of Sucanon vs Metformin as to which reduces blood sugar more. This is pretty unscientific but it looks like results should be very similar based on a "head-to-head" competition.

Metformin:
http://www.diabetesnet.com/about-diabetes/diabetes-medications/metformin

The 3rd paragraph says:
Metformin lowers fasting blood glucose levels by an average of 25% (17 to 37%), postprandial blood glucose up to 44.5%, and the A1c by an average of 1.5% (0.8 to 3.1%).

Sucanon:
http://www.pharmaroth.com/clinical_summary.asp

Clinical studies have shown that Sucanon® reduces blood sugar readings by about 25% - 30% and brings high blood sugar back into the normal range (non-fasting blood sugar is above 200 mg/dL (milligrams per deciliter) or fasting blood sugar is above 126 mg/dL).

More test info: http://www.pharmaroth.com/clinical_results.asp

Looks like it should be a really close competition, but even if Sucanon comes in a little worse than Metformin, Sucanon has no negative side effects.